PLF Pharma are in the process of applying to UK regulators for WDA (Wholesale Distribution Authorisation)
This will allow the company to import EU -GMP finished products (flower /floss / tinctures) to enable them to meet a need in the market both in the NHS and private clinics for those patients with an unmet clinical needs letter in place.
The company are progressing with the conversion of their facility to a multi room cGMP (previously eu-GMP) certified facility and the addition of the WDA will provide a short term solution until certification is obtained.
